| scholarly article | Q13442814 |
| P2093 | author name string | M S Berger | |
| A M Spence | |||
| K A Krohn | |||
| F O'Sullivan | |||
| T K Lewellen | |||
| J M Link | |||
| M M Graham | |||
| M Muzi | |||
| S D Freeman | |||
| G A Ojemann | |||
| B Lewellen | |||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | glucose | Q37525 |
| P304 | page(s) | 440-448 | |
| P577 | publication date | 1998-03-01 | |
| P1433 | published in | The Journal of Nuclear Medicine | Q7743608 |
| P1476 | title | Glucose metabolism in human malignant gliomas measured quantitatively with PET, 1-[C-11]glucose and FDG: analysis of the FDG lumped constant | |
| P478 | volume | 39 |
| Q89643001 | Accuracy of arterial [18F]-Fluorodeoxyglucose uptake quantification: A kinetic modeling study |
| Q34034839 | An analysis of whole body tracer kinetics in dynamic PET studies with application to image-based blood input function extraction |
| Q33863682 | An optimization transfer algorithm for nonlinear parametric image reconstruction from dynamic PET data |
| Q34200294 | CXCL12 mediates trophic interactions between endothelial and tumor cells in glioblastoma |
| Q39953573 | Cellular uptake of PET tracers of glucose metabolism and hypoxia and their linkage. |
| Q36639914 | Current and future use of positron emission tomography (PET) in breast cancer |
| Q36621241 | Early evaluation of tumour metabolic response using [18F]fluorodeoxyglucose and positron emission tomography: a pilot study following the phase II chemotherapy schedule for temozolomide in recurrent high-grade gliomas |
| Q37407235 | Evaluation of the association between HIF-1α and HER-2 expression, hormone receptor status, Ki-67 expression, histology and tumor FDG uptake in breast cancer. |
| Q30730474 | FDG-PET imaging in mild traumatic brain injury: a critical review |
| Q42106975 | Factors affecting tumor (18) F-FDG uptake in longitudinal mouse PET studies |
| Q64103113 | G6Pase location in the endoplasmic reticulum: Implications on compartmental analysis of FDG uptake in cancer cells |
| Q48511703 | Hybrid mathematical model of glioma progression |
| Q64880547 | Imaging Cancer Metabolism: Underlying Biology and Emerging Strategies. |
| Q26861530 | Improving the performance of phase-change perfluorocarbon droplets for medical ultrasonography: current progress, challenges, and prospects |
| Q30574314 | Kinetic Analysis of Dynamic Positron Emission Tomography Data using Open-Source Image Processing and Statistical Inference Tools |
| Q34133581 | Kinetic quantitation of cerebral PET-FDG studies without concurrent blood sampling: statistical recovery of the arterial input function |
| Q35753798 | Measuring response to chemotherapy in locally advanced breast cancer: methodological considerations |
| Q36700360 | Morning-evening variation in human brain metabolism and memory circuits |
| Q42283582 | Multiagent PET for risk characterization in sarcoma |
| Q36539340 | NCI-sponsored trial for the evaluation of safety and preliminary efficacy of 3'-deoxy-3'-[18F]fluorothymidine (FLT) as a marker of proliferation in patients with recurrent gliomas: preliminary efficacy studies |
| Q33510711 | Nonparametric Residue Analysis of Dynamic PET Data With Application to Cerebral FDG Studies in Normals |
| Q34627459 | Platelet Mitochondrial Complex I and I+III Activities Do Not Correlate with Cerebral Mitochondrial Oxidative Metabolism |
| Q35634060 | Selective defect of in vivo glycolysis in early Huntington's disease striatum |
| Q37336539 | The Effects of Capillary Transit Time Heterogeneity (CTH) on the Cerebral Uptake of Glucose and Glucose Analogs: Application to FDG and Comparison to Oxygen Uptake |
| Q36617954 | Uncoupling of fatty acid and glucose metabolism in malignant lymphoma: a PET study. |
| Q35188395 | Use of positron emission tomography in anticancer drug development |
| Q41965733 | Usefulness of positron emission tomographic studies for gliomas |
Search more.